...can be managed through careful dosing and monitoring.Omega Funds previously invested in rare disease play Wilson Therapeutics AB...

...clinical-stage companies. Its takeouts of Achillion Pharmaceuticals Inc. last year, and of Syntimmune Inc. and Wilson Therapeutics AB...

...rare autoimmune disease company Syntimmune Inc., and $855 million in cash to acquire Swedish biotech Wilson Therapeutics AB...

...This year, Alexion gained decuprate bis-choline tetrathiomolybdate (WTX101) through its $855 million cash acquisition of Wilson Therapeutics AB...

...This year, Alexion gained decuprate bis-choline tetrathiomolybdate (WTX101) through its $855 million cash acquisition of Wilson Therapeutics AB...

...He was CFO at medical software company RaySearch Laboratories AB (Stockholm, Sweden) as well as Wilson Therapeutics AB...

...to von Emster, investments from that fund that have yielded double-digit returns include exits from Wilson Therapeutics AB...

...to von Emster, investments from that fund that have yielded double-digit returns include exits from Wilson Therapeutics AB...
...twelfth and leaves it with over $1.2 billion under management. Allison Johnson Abingworth LLP CRISPR Therapeutics AG IFM Therapeutics Inc. Wilson Therapeutics AB...

...June 19 and an MAA to EMA on June 28. Alexion also acquired Swedish biotech Wilson Therapeutics AB...

...United Therapeutics Corp. (NASDAQ:UTHR) SteadyMed Ltd. (NASDAQ:STDY) 4/30/18 $141 $75 $216 Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) Wilson Therapeutics AB...